Danone has acquired The Akkermansia Company to enhance its presence in the gut health sector with innovative probiotic products.

Overview of The Akkermansia Company (TAC)

VIVES Partners announced the acquisition of The Akkermansia Company (TAC) by Danone, a move that underscores Danone's commitment to expanding into the gut health market. Founded in 2016, TAC specializes in biotics and is renowned for its innovative product, Akkermansia muciniphila MucT®, a probiotic strain pivotal for maintaining gut health. This bacterium is naturally occurring in the intestine and serves as a protector of the gut barrier, aiding in inflammation reduction and managing metabolic syndromes such as obesity, diabetes, and cardiovascular diseases.

TAC was established by Professor Willem M. de Vos from Wageningen University and Professor Patrice D. Cani from UCLouvain, who have been instrumental in identifying and researching Akkermansia, a strain recognized globally for its health benefits. The acquisition by Danone is a significant milestone, providing the company with a unique asset to promote Akkermansia on a broader scale.

Industry Overview in Belgium

The biotic sector is gaining increasing recognition, particularly in Belgium, where a strong focus on health and wellness has accelerated market growth. Consumers are moving towards preventive health measur

View Source

Similar Deals

Materialise FEops

2024

Buyout Hospitals, Clinics & Primary Care Services Belgium
Whitestone Lambda-X Ophtalmics

2024

Buyout Glasses, Spectacles & Contact Lenses Belgium
Ceres Pharma CEUMED

2023

Buyout Pharmaceuticals (NEC) Belgium
CellCarta Biogazelle

2021

Buyout Bio Diagnostics & Testing Belgium
Bruker Corporation MOLECUBES NV

2021

Buyout Bio Medical Devices Belgium
IMV Technologies Veterinary Solutions

Buyout Veterinary Medical Equipment & Supplies Belgium

Danone

invested in

The Akkermansia Company (TAC)

in 2025

in a Buyout deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert